CZ20033167A3 - Způsob ošetřování demence a neurodegenerativních chorob středními dávkami LHRH antagonistů - Google Patents

Způsob ošetřování demence a neurodegenerativních chorob středními dávkami LHRH antagonistů Download PDF

Info

Publication number
CZ20033167A3
CZ20033167A3 CZ20033167A CZ20033167A CZ20033167A3 CZ 20033167 A3 CZ20033167 A3 CZ 20033167A3 CZ 20033167 A CZ20033167 A CZ 20033167A CZ 20033167 A CZ20033167 A CZ 20033167A CZ 20033167 A3 CZ20033167 A3 CZ 20033167A3
Authority
CZ
Czechia
Prior art keywords
use according
methyl
lhrh
lhrh antagonist
neurodegenerative diseases
Prior art date
Application number
CZ20033167A
Other languages
Czech (cs)
English (en)
Inventor
Engelájürgen
Voegeliárainer
Original Assignee
Zentariságmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentariságmbh filed Critical Zentariságmbh
Publication of CZ20033167A3 publication Critical patent/CZ20033167A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
CZ20033167A 2001-04-30 2002-04-27 Způsob ošetřování demence a neurodegenerativních chorob středními dávkami LHRH antagonistů CZ20033167A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28743401P 2001-04-30 2001-04-30

Publications (1)

Publication Number Publication Date
CZ20033167A3 true CZ20033167A3 (cs) 2004-08-18

Family

ID=23102886

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20033167A CZ20033167A3 (cs) 2001-04-30 2002-04-27 Způsob ošetřování demence a neurodegenerativních chorob středními dávkami LHRH antagonistů

Country Status (27)

Country Link
US (1) US7288517B2 (cg-RX-API-DMAC7.html)
EP (1) EP1392348B1 (cg-RX-API-DMAC7.html)
JP (1) JP2004529207A (cg-RX-API-DMAC7.html)
KR (1) KR20040000446A (cg-RX-API-DMAC7.html)
CN (1) CN1317030C (cg-RX-API-DMAC7.html)
AT (1) ATE400287T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002310788B2 (cg-RX-API-DMAC7.html)
BG (1) BG108339A (cg-RX-API-DMAC7.html)
BR (1) BR0209290A (cg-RX-API-DMAC7.html)
CA (1) CA2444876A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20033167A3 (cg-RX-API-DMAC7.html)
DE (1) DE60227507D1 (cg-RX-API-DMAC7.html)
DK (1) DK1392348T3 (cg-RX-API-DMAC7.html)
ES (1) ES2307760T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0400067A2 (cg-RX-API-DMAC7.html)
IL (1) IL156777A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03008666A (cg-RX-API-DMAC7.html)
NO (1) NO20034322L (cg-RX-API-DMAC7.html)
NZ (1) NZ544417A (cg-RX-API-DMAC7.html)
PL (1) PL362319A1 (cg-RX-API-DMAC7.html)
PT (1) PT1392348E (cg-RX-API-DMAC7.html)
RU (1) RU2319501C2 (cg-RX-API-DMAC7.html)
SI (1) SI1392348T1 (cg-RX-API-DMAC7.html)
SK (1) SK14512003A3 (cg-RX-API-DMAC7.html)
UA (1) UA80679C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002102401A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200305326B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US20020077327A1 (en) * 1999-09-23 2002-06-20 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1300398B1 (en) 2000-07-05 2006-04-05 Astellas Pharma Inc. Propane-1,3-dione derivatives
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
US7709519B2 (en) * 2004-06-04 2010-05-04 Astellas Pharma Inc. Benzimidazolylidene propane-1,3 dione derivative or salt thereof
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
CA2590997A1 (en) * 2004-12-23 2006-07-06 Voyager Pharmaceutical Corporation Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer`s disease
BRPI0609625A2 (pt) 2005-03-31 2010-04-20 Astellas Pharma Inc derivados de propano-1,3-diona ou sal destes
BRPI0717618A2 (pt) 2006-10-21 2013-10-22 Abbott Gmbh & Co Kg Compostos heterocíclicos e uso dos mesmos como inibidores de glicogênio sintase quinase 3
WO2009043437A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
EP2187917A2 (en) * 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
EP2095818A1 (en) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
US20110129532A1 (en) * 2008-05-29 2011-06-02 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
CN103119035B (zh) 2010-09-27 2015-09-30 雅培股份有限两合公司 杂环化合物和它们作为糖原合成酶激酶-3抑制剂的用途
US9090592B2 (en) 2010-12-30 2015-07-28 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases
WO2025155903A1 (en) * 2024-01-19 2025-07-24 Temple University-Of The Commonwealth System Of Higher Education Compositions of antioxidant translation modulators for treating neurodegenerative disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135743A (en) 1960-06-29 1964-06-02 Sterling Drug Inc Steroido[2. 3-d]isoxazoles and preparation thereof
EP0901489A1 (en) 1996-05-20 1999-03-17 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
WO2000069859A1 (en) * 1999-05-14 2000-11-23 Neurocrine Biosciences, Inc. Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
CA2309395A1 (en) * 1999-06-04 2000-12-04 Richard Lloyd Bowen Methods for preventing and treating alzheimer's disease
KR20020045609A (ko) * 1999-10-15 2002-06-19 추후기재 고나도트로핀-분비 호르몬 수용체 길항제 및 이와 관련된방법
WO2001078780A1 (en) 2000-04-13 2001-10-25 Takeda Chemical Industries, Ltd. Preventives/remedies for alzheimer's disease
EP1300398B1 (en) 2000-07-05 2006-04-05 Astellas Pharma Inc. Propane-1,3-dione derivatives

Also Published As

Publication number Publication date
CN1575185A (zh) 2005-02-02
JP2004529207A (ja) 2004-09-24
EP1392348B1 (en) 2008-07-09
NZ544417A (en) 2008-03-28
US20020177556A1 (en) 2002-11-28
CA2444876A1 (en) 2002-12-27
PL362319A1 (en) 2004-10-18
CN1317030C (zh) 2007-05-23
ATE400287T1 (de) 2008-07-15
ZA200305326B (en) 2003-07-30
NO20034322D0 (no) 2003-09-26
US7288517B2 (en) 2007-10-30
WO2002102401A1 (en) 2002-12-27
RU2319501C2 (ru) 2008-03-20
IL156777A0 (en) 2004-02-08
EP1392348A1 (en) 2004-03-03
UA80679C2 (en) 2007-10-25
HUP0400067A2 (hu) 2004-04-28
ES2307760T3 (es) 2008-12-01
PT1392348E (pt) 2008-09-09
MXPA03008666A (es) 2004-10-15
KR20040000446A (ko) 2004-01-03
DE60227507D1 (de) 2008-08-21
AU2002310788B2 (en) 2007-04-05
BG108339A (bg) 2004-11-30
DK1392348T3 (da) 2008-09-29
SK14512003A3 (sk) 2004-08-03
SI1392348T1 (sl) 2008-12-31
RU2003134949A (ru) 2005-02-10
BR0209290A (pt) 2004-07-13
NO20034322L (no) 2003-09-26
HK1072000A1 (en) 2005-08-12

Similar Documents

Publication Publication Date Title
CZ20033167A3 (cs) Způsob ošetřování demence a neurodegenerativních chorob středními dávkami LHRH antagonistů
AU2002310788A1 (en) Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
EP2720699A2 (en) Administration of benzodiazepine
EP1171124B2 (en) Anthelmintic compositions
DE60132072T2 (de) Verwendungen zur behandlung von fsh-verbundenen zuständen mit gnrh antagonisten
DE69927705T2 (de) Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse
RU2209064C2 (ru) Новое применение в медицинских целях
FI116121B (fi) Menetelmä LHRH-analogin embonaattisuolakoostumuksen valmistamiseksi
US20090054319A1 (en) Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders
EA200401619A1 (ru) Способ управляемой гиперстимуляции яичников и фармацевтический набор для использования в таком способе
CA2120755A1 (en) Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl
HK1072000B (en) Treatment of alzheimer's diseases with intemediate doses of lhrh antagonists
JP2003055238A (ja) 抗骨粗鬆活性を有する組成物
US20040157772A1 (en) Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis
KR100344330B1 (ko) 지속성주사현탁제
CZ294604B6 (cs) Léčivý přípravek pro parenterální podávání z extraktů ze jmelí
US8067382B2 (en) Anthelmintic composition
AU2002305989A1 (en) The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis